Surgical Site Infection Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Surgical Site Infection Control Market is Segmented by Product (Manual Reprocessors Solution, Disinfectants, Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, Other Products), Surgery/Procedure (Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, Other Surgeries/Procedures), Type of Indication (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI), End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Surgical Site Infection Control Market Summary
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.7 %
Surgical Site Infection Control Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Surgical Site Infection Control Market is expected to grow at a CAGR of 5.7% during the forecast period (2022-2027).

The Covid-19 pandemic underlined the critical necessity of hand hygiene and the use of conventional infection control methods, as the World Health Organization and the Centers for Disease Control and Prevention (CDC) recommended, in reducing the number of surgical site infections. During the Covid-19 epidemic, surgical site infection rates were reported to have decreased in healthcare settings. For instance, according to the article published in the National Library of Medicine in September 2020, by Pasquale Losurdo, during the SARS-CoV-2 lockdown, the total number of SSIs was drastically reduced, especially for superficial and deep SSIs. This may be due to a reduction in the number of surgical procedures and also due to increased focus on infection prevention with the wide usage of PPE kits and other sanitary regulations. Thus, the COVID-19 pandemic has increased the need for surgical site infection control products and may drive the growth of the market.

The increasing hospital-acquired infections and surgeries have increased and risen in the geriatric population. According to the Centers for Disease Control and Prevention, Hospital Associated Infection Progress report 2020, in the United States, there are 425 surgical site infections were observed due to open reduction of the fracture, 222 due to gall bladder surgery, 311 due to laminectomy surgery, and 496 due to cesarean section surgery. Such a high incidence of surgical site infection in the country is expected to drive the growth of the market.

Furthermore, according to the United Nations' World Ageing Population 2020 highlights, the number of people aged 65 years or above is expected to double by 2050, from 727 million in 2020 to 1.5 billion in 2050. This age group is at a higher risk for various age-related illnesses and surgical site infection, which has resulted in higher adoption of SSI control products, preventing infections among people. Thus the market will grow over the forecast period as the population ages.

Additionally, in January 2020, Becton, Dickinson, and Company launched BD PurPrep patient preoperative skin preparation with a sterile solution. It is one of the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation (PVP-I; 0.83% available iodine and 72.5% isopropyl alcohol) commercially available in the United States.

However, a lack of awareness about SSI among individuals restrained the market over the forecast period.

Scope of the Report

As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ-related. The Surgical Site Infection Control Market is segmented by Product (Manual Reprocessors Solution, Disinfectants, Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, Other Products), Surgery/Procedure (Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, Other Surgeries/Procedures), Type of Indication (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI), End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

By Product
Manual Reprocessors Solution
Disinfectants
Hand Disinfectants
Skin Disinfectants
Surgical Scrubs
Hair Clippers
Surgical Drapes
Surgical Irrigation
Skin Preparation Solution
Medical Nonwovens
Surgical Gloves
Other Products
By Surgery/Procedure
Cataract Surgery
Cesarean Section
Dental Restoration
Gastric Bypass
Other Surgeries/Procedures
By Type of Infection
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
By End User
Hospitals
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Superficial Incisional Segment is Expected to Exhibit Fast Growth Rate Over the Forecast Period

Only skin and subcutaneous tissue of the incision are infected in a superficial incisional SSI. This infection occurs only in the area where the incision was made on the skin. The rate of superficial incision SSI is expected to boost the segment growth. According to the article titled "Impact of lockdown for SARS-CoV-2 (COVID-19) on surgical site infection rates: a monocentric observational cohort study" published in September 2020, in the COVID-19 era, the rate of global SSIs was 3.3%, and superficial SSIs was 0.8 %. Such a rate of superficial surgical site infection creates the need for infection control products and thus drives the growth of the market segment.

The rising incidence of hospital-acquired infections, a growing geriatric population, and subsequent growth in the prevalence of chronic diseases are expected to boost the segment as per the study titled "Healthcare-Associated Infections A New Pathology in Medical Practice?" published in February 2020, about 50% of hospital-acquired infections occur in the intensive care unit (ICU).

The outbreak of COVID-19 has significantly impacted the growth of the SSI market. The usage of superficial incisional SSI control that protects healthcare facilities and safeguards personnel performing medical procedures that expose them to the virus is rising.​ As a result, several companies have increased their production and are focusing on developing new products.

Additionally, in May 2021, Becton, Dickinson, and Company launched BD Surgiphor Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris. Such launches are expected to propel the growth of the market.

Thus, all the factors above, such as rising surgical site infection and hospital-acquired disorders, boost the segment growth.

Surgical Site Infection Control Market : Number of Surgical Site Infection in Acute Care Hospitals (In Thousands), By Procedure, United States, 2020

North America Captured the Large Market Share and is Expected to Retain its Dominance

The surgical site infection control market has been dominated by North America, with the United States accounting for the largest share of regional revenue. SSIs are the most common healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States (tied with pneumonia). According to the Center for Disease Control and Prevention, Healthcare Associated Infection Progress Report 2020, there are nearly 18,416 surgical site infections are reported in 2020 in the United States. It also reported that out of these 6.094 infection were during colon surgery and 2,173 occured during hip arthroplasty. Such high rate of surgical site infection creates the need for SSIC products and thus propells the growth of the market.

According to 2022 data by the American Health Association, there were approximately 33,356,853 hospital admissions in 2022. Many of these admissions were due to chronic diseases and critical procedures, like heart bypass surgery. Thus increasing number of hospital admissions is expected to have more SSIs, thereby boosting the market in the region.

Thus, all factors above are expected to boost the market in the region over the forecast period.

Surgical Site Infection Control Market - Growth Rate by Region

Competitive Landscape

The Surgical Site Infection Control market is moderately competitive. 3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Group, and Johnson & Johnson are some significant players in the surgical site infection control market. The competitive rivalry of the market studied has intensified, owing to the constant product innovations worldwide.

Recent Development

  • In April 2022, Mölnlycke expands in Malaysia with the construction of a new surgical glove factory. The company is increasing its manufacturing capacity to ensure that it can continue to satisfy the growing demand for Biogel gloves.
  • In March 2022, Invenio launches a new series of surgical gowns named the V90 surgical gown series.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Hospital Acquired Infection

      2. 4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control

      3. 4.2.3 Increasing Number of Surgeries

      4. 4.2.4 Rapidly Growing Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness of Hospital Infection Prevention and Control

      2. 4.3.2 Increased Use of Outpatient Treatment

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Product

      1. 5.1.1 Manual Reprocessors Solution

      2. 5.1.2 Disinfectants

        1. 5.1.2.1 Hand Disinfectants

        2. 5.1.2.2 Skin Disinfectants

      3. 5.1.3 Surgical Scrubs

      4. 5.1.4 Hair Clippers

      5. 5.1.5 Surgical Drapes

      6. 5.1.6 Surgical Irrigation

      7. 5.1.7 Skin Preparation Solution

      8. 5.1.8 Medical Nonwovens

      9. 5.1.9 Surgical Gloves

      10. 5.1.10 Other Products

    2. 5.2 By Surgery/Procedure

      1. 5.2.1 Cataract Surgery

      2. 5.2.2 Cesarean Section

      3. 5.2.3 Dental Restoration

      4. 5.2.4 Gastric Bypass

      5. 5.2.5 Other Surgeries/Procedures

    3. 5.3 By Type of Infection

      1. 5.3.1 Superficial Incisional SSI

      2. 5.3.2 Deep Incisional SSI

      3. 5.3.3 Organ or Space SSI

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Ambulatory Surgical Centers

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 3M

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Belimed AG

      4. 6.1.4 Getinge Group

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Kimberly-Clark Corporation

      7. 6.1.7 Sotera Health

      8. 6.1.8 Ansell Limited

      9. 6.1.9 Steris Corporation

      10. 6.1.10 Lac-Mac Limited

      11. 6.1.11 Pacon Manufacturing Corp.

      12. 6.1.12 American Polyfilm Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Surgical Site Infection Control Market market is studied from 2019 - 2027.

The Global Surgical Site Infection Control Market is growing at a CAGR of 5.7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Getinge Group, Steris Healthcare, 3M, Becton, Dickinson and Company, Belimed AG are the major companies operating in Global Surgical Site Infection Control Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!